ArticleFrontiers in endocrinology2025
Association of UHR and ECG parameters with type 2 diabetes mellitus in non-alcoholic fatty liver disease.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease globally. NAFLD increases the risk of type 2 diabetes mellitus (T2DM) while lacking clinical predictors. This study aims to investigate the characteristics and clinical significance of the uric acid (UA) to high-density lipoprotein cholesterol ratio (UHR) and electrocardiogram (ECG) parameters in NAFLD patients, both with and without T2DM. Methods: We compared 102 NAFLD with T2DM (NAFLD-T2DM) cases to 113 NAFLD without T2DM (NAFLD-nT2DM) cases. Baseline data and biochemical indicators, including UHR, were collected and analyzed in each group. A 12-lead ECG was used to collect parameters that were compared between the two groups. Multivariate logistic regression analysis was employed to identify factors influencing NAFLD with T2DM. Receiver operating characteristic (ROC) curves were utilized to assess the clinical value of UHR combined with ECG parameters in identifying T2DM risk among NAFLD patients. Results: Compared to the NAFLD-nT2DM group, the NAFLD-T2DM group exhibited significantly higher levels of triglycerides (TG), fasting plasma glucose (FPG), UA, and UHR, while aspartate aminotransferase (AST) levels were lower (P < 0.05). The incidence of ST-T changes, heart rate, and P wave duration was also higher in the NAFLD-T2DM group, whereas the QT interval was shorter (P < 0.05). Multivariate logistic regression analysis revealed that UHR, ST-T changes, heart rate, QT interval, and P wave duration are independent factors associated with the incidence of T2DM in NAFLD. ROC curve analysis indicated that the area under the curve (AUC) for the combination of five variables in predicting T2DM in NAFLD was 0.949 (95% CI: 0.905-0.977, P < 0.05), with a sensitivity of 91.96% and a specificity of 93.55%, significantly superior to those of individual indicators. Conclusion: UHR and ECG parameters are associated with T2DM in NAFLD patients. The combination of UHR and ECG parameters demonstrates predictive value for the incidence of T2DM in NAFLD patients. Clinical attention should be directed toward the levels of UHR and ECG parameters in NAFLD with T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.